Sell side is looking reasonably thin but will need a bit to push it north. Hopefully an announcement soon. Market will catch on eventually. Still surprised to see where it's sitting. Cheap valuation atm.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025